Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by Benedict16thon Jun 26, 2019 7:04am
83 Views
Post# 29863647

RE:RE:RE:RE:RE:RE:RE:Meir, A man of his Word, Starts Pharma in Canada

RE:RE:RE:RE:RE:RE:RE:Meir, A man of his Word, Starts Pharma in CanadaMeir always had a plan B, he planted the seeds and made institutional investors aware of the GUD MNGT sub-par action. Meir further alleged that MNGT greater actions and interest lied else where but not in GUD thus far. Institutional investors have fiiduciary duties to  their own investors/clients just as it should be for GUD MNGT but Meir alleged great doubts about it. I suspect that institutional investors are now doing their on D&D with a microscope looking for real action and  facts. They will no longer listen to "talk...talk...I was great and I will be great again" Meir know such and he is going to harvest the seeds that he planted as well he understans canadian investors. Many action are available to him togheter with other GUD investors including a GUD buy out. Every GUD investor is warming up to Meir while getting cold on JG. Five Years is a long time. Have GUD BOD and MNGT manged the rest of their invetments the same way they have managed GUD cash? If yes ....ok and stay, but if no they need to move on ............. 11 months and counting. 
Bullboard Posts